Cargando…
Poly(d,l-lactide-co-glycolide)–chitosan composite particles for the treatment of lung cancer
Tumor heterogeneity makes combination chemotherapy one of the preferred modes of treatment regimens. In this work, sequential exposure of two anticancer agents, paclitaxel (Tx) followed by topotecan (TPT), was shown to have a synergistic effect on non-small cell lung cancer (NSCLC) cell line, NCI-H4...
Autores principales: | Arya, Neha, Katti, Dhirendra S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406260/ https://www.ncbi.nlm.nih.gov/pubmed/25945047 http://dx.doi.org/10.2147/IJN.S78120 |
Ejemplares similares
-
A one-step electrospray-based technique for modulating morphology and surface properties of poly(lactide-co-glycolide) microparticles using Pluronics(®)
por: Seth, Anushree, et al.
Publicado: (2012) -
Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes
por: Cosco, Donato, et al.
Publicado: (2014) -
Influence of Hydroxyapatite Surface Functionalization on Thermal and Biological Properties of Poly(l-Lactide)- and Poly(l-Lactide-co-Glycolide)-Based Composites
por: Gazińska, Małgorzata, et al.
Publicado: (2020) -
Glycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptake
por: Lamichhane, Surya P, et al.
Publicado: (2015) -
Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin
por: Cardoso, M. Margarida, et al.
Publicado: (2021)